Role of pharmacoeconomics in developing countries

Role of pharmacoeconomics in developing countries

Authors

  • Amani Mori
  • Paul Gavaza Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
  • Bjarne Robberstad Appalachian College of Pharmacy, Oakwood, Virginia, USA

DOI:

https://doi.org/10.7175/fe.v14i1.638

References

WHO: Equitable access to essential medicines: a framework for collective action. Geneva: World Health Organization, 2004

WHO: The world medicine situation. Geneva: World Health Organization, 2011

Cameron A, Ewen M, Ross-Degnan D, et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009; 373: 240-9; http://dx.doi.org/10.1016/S0140-6736(08)61762-6

Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. Third edition. New York: Oxford University Press, 2005

Hogerzeil HV. The concept of essential medicines: lessons for rich countries. BMJ 2004; 329:1169-1171; http://dx.doi.org/10.1136/bmj.329.7475.1169

Mori AT, Robberstad B. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Med Inform Decis Mak 2012; 12: 110; http://dx.doi.org/10.1186/1472-6947-12-110

Gavaza P, Rascati KL, Oladapo AO, et al. The State of Health Economic Research in South Africa: A Systematic Review. Pharmacoeconomics 2012, 30: 925-40; http://dx.doi.org/10.2165/11589450-000000000-00000

Gavaza P, Rascat KL, Oladapo AO, et al.The State of Health Economic Evaluation Research in Nigeria: A Systematic Review. Pharmacoeconomics 2010, 28: 539-53

Gavaza P, Rascati K, Brown C, et al. The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: a review. Current Therapeutic Research 2008; 69: 268-85; http://dx.doi.org/10.1016/j.curtheres.2008.06.005

Babar Z, Scahill S. Is there a role for pharmacoeconomics in developing countries? Pharmacoeconomics 2010; 28: 1069-74; http://dx.doi.org/10.2165/11584890-000000000-00000

Pooja RD, Hitesh CS, Rascati KL. Assessing the quality of pharmacoeconomic studies in India: a systematic review. Pharmacoeconomics 2012; 30: 749-62; http://dx.doi.org/10.2165/11590140-000000000-00000

Tarn YH, Hu S, Kamae I, et al. Health-care systems and pharmacoeconomic research in Asia-Pacific Region. Value in Health 2008; 1(Supp 1): S137-5; http://dx.doi.org/10.1111/j.1524-4733.2008.00378.x

Mori AT, Kaale EA. Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework. Implement Sci 2012; 7: 18; http://dx.doi.org/10.1186/1748-5908-7-18

Wiseman V, Kim M, Mutabingwa TK, et al. Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med 2006; 3: e373; http://dx.doi.org/10.1371/journal.pmed.0030373

Chanda P, Masiye F, Chitah BM, et al. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia. Malar J 2007; 6: 21

Muheki C, McIntyre D, Barnes KI. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health 2004; 9: 959-66; http://dx.doi.org/10.1111/j.1365-3156.2004.01292.x

Pillay A. Role of pharmacoeconomics in a developing country context. In International Conference on Improving Use of Medicines. Antalya, Turkey, 2011

Abdulla S, Goodman C, Coleman P, et al. The costs, effects and cost-effectiveness of changing the first line drug for treatment of malaria in Tanzania. Health Economics and Financing Program working paper 01/2000

Downloads

Published

2013-01-30

How to Cite

Mori, A., Gavaza, P., & Robberstad, B. (2013). Role of pharmacoeconomics in developing countries. Farmeconomia. Health Economics and Therapeutic Pathways, 14(1), 3–5. https://doi.org/10.7175/fe.v14i1.638

Issue

Vol. 14 No. 1 (2013)

Section

Editorial

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)